Tirzepatide Firm (Pharma), {formerly Bachem Pharma, with no affiliation with Bachem AG,} is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, with over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide, offering a comprehensive range of services. Bachemistry operates internationally with headquarters in Switzerland and locations in Europe, the US, and Asia. The company is listed on the SIX Swiss Exchange.
The GMP site in Garland, Texas, is the clean room center of excellence for the ry Americas organization in the development of new chemical entities (NCEs), with in-depth knowledge and expertise in chemistry, manufacturing, and controls (CMC) to achieve successful commercialization. Together with state-of-the-art equipment and a rapidly growing degree of automation, the Garland site delivers efficient peptide active pharmaceutical ingredient (API) development and manufacturing on a small to medium scale.
The Houston location manufactures commercial API, peptide, new chemical entities (NCEs), and intermediates using state-of-the-art equipment and facilities. Since its acquisition, the site has undergone significant capacity expansion to meet the market demand for peptide products on a medium and larger scale. The site also provides custom synthesis for research-grade peptides. The Texas location private-labels a full range of affordable, reliable consumer products, skincare medicines, generic store brand OTCs, and branded self-care products, improving health and wellness for consumers worldwide.
